About Parmax Pharma
Parmax Pharma is a publicly listed company based in Rajkot (India) founded in 1994. The company has 9 employees. Its Indian entity Parmax Pharma Limited reported revenue of ₹28.24 Cr. Parmax Pharma offers products and services including Active Pharmaceutical Ingredients, Contract Manufacturing Operations, and Bulk Drugs. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Parmax Pharma Ltd was established in 1994 and is based in Rajkot, India. Operations are centered in the pharmaceutical sector, where bulk drugs, drug intermediates, and specialty chemicals are manufactured and sold. Scientific expertise is applied alongside manufacturing capabilities to support activities in the pharmaceutical segment and related industries.
- Headquarters Rajkot, India
- Employees 9
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website parmaxpharma.com
- Legal Name Parmax Pharma Ltd.
- Annual Revenue₹28.24 Cr
FY 2025 · +154% YoY
- Net Loss-₹2.09 Cr
FY 2025 · -7% margin
- EBITDA-₹77.8 Lakh
FY 2025 · -3% margin
- Employee Count9
Associated legal entities of Parmax Pharma
Parmax Pharma operates through Parmax Pharma Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Parmax Pharma Limited Listed CIN L24231GJ1994PLC023504 | Active | 02 Nov 1994 | Hadamtala, Gujarat | ₹28.2 Cr | 9 | 7 | View details |
Products & Services of Parmax Pharma
Parmax Pharma offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Contract Manufacturing Operations, and Bulk Drugs.
Production of complex molecules for pharmaceutical formulations using advanced techniques.
Custom manufacturing services for pharmaceutical companies' needs and requirements.
Creation of essential drugs like Ampicilin for industry use.
Board of directors of Parmax Pharma Limited (Parmax Pharma)
Parmax Pharma Limited is the primary company behind Parmax Pharma. The board of Parmax Pharma Limited currently have 5 directors; the longest-serving is Umang Alkesh Gosalia, appointed in 2016. 14 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Umang Alkesh Gosalia DIN 05153830 | Managing Director | 02 Jan 2016 | 10 yrs 9 mo | Parmax Pharma Limited |
| Ami Shah Rajeshbhai DIN 08158605 | Director | 17 Jun 2018 | 8 yrs 4 mo | Parmax Pharma Limited |
| Nikhil Sureshchandra Uchat DIN 08427983 | Director | 25 Apr 2023 | 3 yrs 6 mo | Parmax Pharma Limited |
| Pradeep Ramniklal Gosalia DIN 01130646 | Director | 27 May 2026 | 5 mo | Parmax Pharma Limited |
| Salma Badrudin Thobhani DIN 11616267 | Director | 27 May 2026 | 5 mo | Parmax Pharma Limited |
People of Parmax Pharma
1 people are tracked at Parmax Pharma (1 in leadership); the tracked headcount is 9.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership |
Complete people profiles for Parmax Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Parmax Pharma
Parmax Pharma is a publicly listed company on the BSE with ticker symbol PARMAX in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 Mar 2017
- Listed onBSE: 540359
- Listed entityParmax Pharma Ltd.
- Exchange sectorHealth technology
- ISININE240T01014
- Share price₹137.75 (-0.97% on the day) · 2026-10-12
- Volume (last session)1,506
Financials of Parmax Pharma
Figures of Parmax Pharma Limited, the primary company behind Parmax Pharma, for FY 2025. Revenue was ₹28.24 Cr (+154% year on year). Net loss was -₹2.09 Cr (-7% margin). EBITDA was -₹77.8 Lakh (-3% margin). Revenue has grown at a compounded annual rate of +16% over three years and +6% over five years.
- ₹28.24 CrRevenue · FY 2025 · +154% YoY
- -₹2.09 CrNet loss · -7% margin
- -₹77.8 LakhEBITDA · -3% margin
- ₹3.74 CrPaid-up capital
- 9Employees (provident fund records)
- +16%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Parmax Pharma Limited are on its company page.
Detailed financial statements for Parmax Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Parmax Pharma
Parmax Pharma has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Parmax Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Parmax Pharma
Websites that share an audience with Parmax Pharma (parmaxpharma.com).
Websites whose visitors overlap most with Parmax Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
paramaxcorp.com | paramaxcorp.com | 100% | #6,617,096 | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Parmax Pharma (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Parmax Pharma
Complete news archive for Parmax Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parmax Pharma
Parmax Pharma was founded in 1994.
Parmax Pharma is headquartered in Rajkot, India. It is registered at Rajkot, Gujarat, India.
Parmax Pharma has 9 employees.
The primary company behind Parmax Pharma, Parmax Pharma Limited, reported revenue of ₹28.24 Cr for FY 2025, up 154% year on year.
Parmax Pharma Ltd was established in 1994 and is based in Rajkot, India. Operations are centered in the pharmaceutical sector, where bulk drugs, drug intermediates, and specialty chemicals are manufactured and sold. Scientific expertise is applied alongside manufacturing capabilities to support activities in the pharmaceutical segment and related industries.
Parmax Pharma's top competitors include Laurus Labs, Symbiotec and SeQuent.
Parmax Pharma offers Active Pharmaceutical Ingredients, Contract Manufacturing Operations, and Bulk Drugs.
Yes, Parmax Pharma is publicly traded on BSE under the ticker symbol PARMAX.
Parmax Pharma operates through Parmax Pharma Limited.
The legal entities of Parmax Pharma currently have 7 directors, including Ami Shah Rajeshbhai, Keyur Dineshbhai Vora, Umang Alkesh Gosalia and others.